Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma

de Castria, TB; Khalil, DN; Harding, JJ; O'Reilly, EM; Abou-Alfa, GK

Abou-Alfa, GK (通讯作者),Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.;Abou-Alfa, GK (通讯作者),Cornell Univ, Weill Med Coll, New York, NY 10021 USA.

FUTURE ONCOLOGY, 2022; 18 (33): 3769

Abstract

Liver cancer is the third most common cause of cancer-related mortality worldwide, with over 780,000 deaths in 2018. About 90% of liver cancer cases a......

Full Text Link